News

Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select non-core over-the-counter (OTC) and prescription pharmaceutical…
Read More...

Affinivax, Inc. a clinical stage biotechnology company with its novel MAPS technology platform for vaccines and immunotherapies, announced the completion of a $120 million Series B…
Read More...

Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer, announces that it has initiated a research programme to develop a vaccine for COVID-19. The…
Read More...

ProThera Biologics, Inc. and Takeda Pharmaceutical Company Limited announced that they have entered into a global licensing agreement to develop a novel plasma-derived Inter-alpha…
Read More...

Catalent announced the completion of its $14 million expansion to increase the biologics packaging capabilities and capacity at its Bloomington, Indiana facility. The completed…
Read More...

Griffith University researchers have joined forces with scientists from Indian Immunologicals Limited (IIL), a leading vaccines manufacturing company based in Hyderabad, India to…
Read More...

Diamond Pharma Services announced its pharmacovigilance division, Diamond PV Services, has acquired PharmaCentral (https://pharmacentral.ie/), an innovative pharmacovigilance services…
Read More...

Data from the Phase III REACH2 study published today in The New England Journal of Medicine show Jakavi (ruxolitinib) improves outcomes across a range of efficacy measures in patients…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to Kymriah (tisagenlecleucel), for an investigational…
Read More...

After cities shut down and citizens were urged to stay home to slow the spread of Covid-19, scientists in major cities like Boston were suddenly far removed from their labs. At MIT,…
Read More...

Targovax ASA, a clinical stage immuno-oncology company developing oncolytic viruses and cancer vaccines to target hard-to-treat solid tumors, and Valo Therapeutics (Valo Tx) announce…
Read More...

Asklepios BioPharmaceutical, Inc. (AskBio) announced that it has acquired BrainVectis, a Paris-based gene therapy company and French National Institute for Health and Medical Research…
Read More...

Aptar and Sonmol have announced a collaboration for developing a digital therapies and services platform targeting respiratory and other diseases. This collaboration will initially…
Read More...

Mogrify Ltd (Mogrify), a UK company aiming to transform the development of cell therapies by the systematic discovery of novel cell conversions, and Sangamo Therapeutics (Sangamo), a…
Read More...

Boehringer Ingelheim announced that the European Commission has approved nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults. The…
Read More...

Nexus Pharmaceuticals announced that it has received U.S. Food and Drug Administration (FDA) approval for its patent-pending New Drug Application (NDA) Emerphed, the first and only…
Read More...

Novartis announced new Mayzent (siponimod) data in the April supplemental issue of Neurology, the medical journal of the American Academy of Neurology. The data build on existing…
Read More...

Gilead Sciences, Inc. Kite, a Gilead Company, and oNKo-innate announced the companies have entered into a three-year cancer immunotherapy research collaboration to support discovery and…
Read More...

Hope Biosciences announces FDA approval on their third clinical trial for COVID-19. This study will be conducted in collaboration with Advanced Diagnostics Healthcare (ADH) at River…
Read More...

Anixa Biosciences, Inc. announced that it has entered into a strategic collaboration with OntoChem GmbH to discover and develop anti-viral drug candidates for COVID-19. Dr. Amit…
Read More...